Research Article
A Quasi-Experimental Study of Dengue Hemorhagic Fever Grade 1 and 2 Clinical Pathway Implementation in Universitas Sumatera Utara Hospital
@INPROCEEDINGS{10.4108/eai.4-12-2019.2293799, author={Ivana Alona and Andike Aribi and Juliandi Harahap}, title={A Quasi-Experimental Study of Dengue Hemorhagic Fever Grade 1 and 2 Clinical Pathway Implementation in Universitas Sumatera Utara Hospital}, proceedings={The 3rd International Conference Community Research and Service Engagements, IC2RSE 2019, 4th December 2019, North Sumatra, Indonesia}, publisher={EAI}, proceedings_a={IC2RSE}, year={2020}, month={4}, keywords={dhf hospital cost clinical pathways cost control quality control}, doi={10.4108/eai.4-12-2019.2293799} }- Ivana Alona
Andike Aribi
Juliandi Harahap
Year: 2020
A Quasi-Experimental Study of Dengue Hemorhagic Fever Grade 1 and 2 Clinical Pathway Implementation in Universitas Sumatera Utara Hospital
IC2RSE
EAI
DOI: 10.4108/eai.4-12-2019.2293799
Abstract
Clinical pathways are essential to control cost and quality performance. The data of its implementation in USU Hospital was absent. This study aimed to assess the compliance of DHF CP implementation on diagnostic, treatment and hospital cost. This study was using quasi-experimental design. An intervention of CP socialization was conducted in 2019. The data were obtained from CP, Medical Record, financial unit, and Hospital Information System. A total of 100 DHF grade 1 and 2 cases were analyzed using SPSS. We found that the intervention improved the compliance of intravenous solution (p=0.096), drugs (p=0.001); reduced hospital adjusted cost (Rp. 481,165.42, p=0.002), laboratory cost (Rp. 205,535, p=0.012) and LOS (0.64 day, p=0.019). There was no statistical difference in laboratory test compliance (p =0.3) and drug cost (p= 0.113) between the CP groups. In conclusion, the implementation of DHF CP improved the overall hospital cost and variance of drugs.
